New antibody shows promise against dangerous staph blood infections
Disease control
Completed
This study tested a new human antibody called 514G3 in 52 hospitalized patients with Staphylococcus aureus bloodstream infections. Participants received either a single dose of the antibody plus standard antibiotics or a placebo plus antibiotics. The goal was to check safety and …
Phase: PHASE1, PHASE2 • Sponsor: XBiotech, Inc. • Aim: Disease control
Last updated May 11, 2026 20:40 UTC